Benitec Biopharma Limited Analysis
| Analyst Ratings |
|
Average Target Price
|
4.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.18
|
-0.47
|
-0.29
|
-161.11%
|
|
2022-06-30
|
-0.28
|
-0.62
|
-0.34
|
-121.43%
|
|
2022-03-31
|
-0.44
|
-0.40
|
0.04
|
9.09%
|
|
2021-12-31
|
-104.47
|
-0.59
|
103.88
|
99.44%
|
|
2021-09-30
|
-128.15
|
-0.62
|
127.53
|
99.52%
|
|
2021-06-30
|
-0.93
|
-0.57
|
0.36
|
38.71%
|
|
2021-03-31
|
-0.85
|
-0.82
|
0.03
|
3.53%
|
|
2020-12-31
|
-0.75
|
-0.76
|
-0.01
|
-1.33%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.47
|
|
2022-06-30
|
-2.23
|
|
2021-06-30
|
-4.60
|
|
2020-06-30
|
-4.31
|
|
2019-06-30
|
-1.97
|
|
2018-06-30
|
-2.44
|